Prime Minister Boris Johnson delivers an update on the Covid-19 coronavirus pandemic during a virtual press conference at 10 Downing Street on March 18, 2021 in London, England.
Tolga Akmen – WPA Pool | fake images
LONDON – UK Prime Minister Boris Johnson is expected to receive the first dose of the coronavirus vaccine developed by AstraZeneca and the University of Oxford on Friday, with the aim of reassuring the public that the vaccine is safe and secure. effective.
Johnson, 56, has urged others to get vaccinated against Covid-19, citing data from the UK’s independent drug regulator showing the benefits far outweigh the risks.
A number of countries around the world discontinued the use of the Oxford-AstraZeneca vaccine as a precautionary measure following reports of blood clots in some vaccinated people. Health experts harshly criticized the move, citing the lack of data, while analysts expressed concern about the impact on the absorption of the vaccine as the virus continues to spread.
UK and EU regulators have said there is no evidence that the Covid vaccine caused blood clots. The World Health Organization also said that the benefits of the Oxford-AstraZeneca vaccine outweigh the risks and recommended that vaccinations continue.
Speaking at a Downing Street conference on Thursday, Johnson said the Oxford-AstraZeneca vaccine was safe, but “what is not safe is contracting Covid, which is why it is so important that we all take our hits as soon as it is our turn. . “
The UK leader was treated in hospital for Covid-19 in April last year and spent days in an intensive care unit.
French Prime Minister Jean Castex is also expected to receive the Oxford-AstraZeneca vaccine on Friday.
Germany, France, Italy and Spain are among some of the Europeans who say they will use the vaccine again after the European drug regulator declared it safe and effective. Indonesia, which had previously delayed administering the injection, said on Friday it had approved the use of the Oxford-AstraZeneca vaccine.
Norway, Sweden and Denmark, however, have said they will continue to stop use of the vaccine while they conduct their own independent reviews.
The UK, which did not stop launching the Oxford-AstraZeneca injection, said delays in the supply of vaccines next month would not affect England’s roadmap out of the lockdown.
A health worker holds a box of AstraZeneneca vaccine at the Bamrasnaradura Infectious Diseases Institute in Nonthaburi province, outside Bangkok.
Chaiwat Subprasom | Images SOPA | LightRocket via Getty Images
The National Health Service had warned of a “significant reduction” in the weekly supply of Covid vaccines in England next month, after fewer doses than initially expected arrived from India.
Johnson said there were “no changes” to the government’s plan to ease restrictive public health measures, insisting the roadmap was “on track” despite an unexpected drop in vaccine supplies.
To date, more than 4.2 million people have contracted Covid in the UK, with 126,163 deaths, according to data compiled by Johns Hopkins University.